AIMC Topic: Drug Discovery

Clear Filters Showing 661 to 670 of 1550 articles

Deep Learning and Structure-Based Virtual Screening for Drug Discovery against NEK7: A Novel Target for the Treatment of Cancer.

Molecules (Basel, Switzerland)
NIMA-related kinase7 (NEK7) plays a multifunctional role in cell division and NLRP3 inflammasone activation. A typical expression or any mutation in the genetic makeup of NEK7 leads to the development of cancer malignancies and fatal inflammatory dis...

GraphDPA: Predicting drug-pathway associations by graph convolutional networks.

Computational biology and chemistry
Pathway-based drug discovery is a promising strategy for the discovery of drugs with low toxicity and side effects. However, identifying the associations between drug and targeting pathways is challenging for this method. The formation of various bio...

Predicting In Vivo Compound Brain Penetration Using Multi-task Graph Neural Networks.

Journal of chemical information and modeling
Assessing whether compounds penetrate the brain can become critical in drug discovery, either to prevent adverse events or to reach the biological target. Generally, pre-clinical in vivo studies measuring the ratio of brain and blood concentrations (...

Drug-target interaction prediction using reliable negative samples and effective feature selection methods.

Journal of pharmacological and toxicological methods
Machine learning-based approaches in the field of drug discovery have dramatically reduced the time and cost of the laboratory process of detecting potential drug-target interactions (DTIs). Standard binary classifiers require both positive and negat...

Exploring Low-Toxicity Chemical Space with Deep Learning for Molecular Generation.

Journal of chemical information and modeling
Creating a wide range of new compounds that not only have ideal pharmacological properties but also easily pass long-term toxicity evaluation is still a challenging task in current drug discovery. In this study, we developed a conditional generative ...

Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.

International journal of molecular sciences
Diffuse large B cell lymphoma (DLBCL) is an aggressive heterogeneous disease. The most common subtypes of DLBCL include germinal center b-cell (GCB) type and activated b-cell (ABC) type. To learn more about the pathogenesis of two DLBCL subtypes (i.e...

Empowering the discovery of novel target-disease associations via machine learning approaches in the open targets platform.

BMC bioinformatics
BACKGROUND: The Open Targets (OT) Platform integrates a wide range of data sources on target-disease associations to facilitate identification of potential therapeutic drug targets to treat human diseases. However, due to the complexity that targets ...

Maximizing the integration of virtual and experimental screening in hit discovery.

Expert opinion on drug discovery
INTRODUCTION: Experimental and virtual screening contributes to the discovery of more than 50% of clinical candidates. Considering the similar concept and goals, early-phase drug discovery would benefit from the effective integration of these approac...